Rezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress

NEXT STORY
BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO
PREV STORY
Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Sparsentan in Europe, Australia and New Zealand
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cempra to Present at Two Upcoming Investor Conferences

CHAPEL HILL, N.C., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

author_avatar
NASDAQ Market News

COVID-19 Testing Market Update 2021: A 38 Billion Dollar Market for COVID-19 Test Products: Molecular, Antigen, and Antibody Tests

author_avatar
NASDAQ Market News

Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial

author_avatar
NASDAQ Market News